Navigation Links
Pro-Dex, Inc. Announces Fiscal Third Quarter And Nine-Month Results
Date:5/13/2013

,000 of costs associated with the contested election of directors that culminated during the quarter.  Included in operating expenses for the 2012 quarter were separation costs related to a previous Chief Executive Officer's resignation amounting to $339,000.

Loss from continuing operations for the quarter ended March 31, 2013 was $765,000, compared to a loss from continuing operations of $547,000 in the corresponding quarter in 2012.  Net loss for the quarter ended March 31, 2013 was $747,000, or $0.22 per diluted share, compared to a net loss of $487,000, or $0.15 per diluted share, for the corresponding quarter in 2012.

During the quarter ended March 31, 2013, the Company used $490,000 of cash in operating activities.  This use of cash reflects primarily the aforementioned separation payments and the proxy contest costs.

Nine Months Ended March 31, 2013Sales for the nine months ended March 31, 2013 decreased 30% to $9.5 million from $13.6 million in the corresponding nine-month period in 2012.  Excluding sales to the Company's former largest customer, which represented a reduction of $5.5 million in the nine months ended March 31, 2013 from the corresponding period in 2012, sales of surgical instruments increased $1.3 million, or 30%, in the nine months ended March 31, 2013 when compared to the 2012 period, 62% of which arose from increased sales to the Company's current largest customer.

For the nine months ended March 31, 2013, gross profit was $3.2 million, or 33%, compared to $4.6 million and 34%, respectively, for the corresponding period in 2012. This decrease in gross profit as a percentage of sales resulted primarily from unfavorable changes in product mix, partially offset by a reduction in warranty costs.

Operating expenses for the nine months ended March 31, 2013 decreased 17% to $4.4 million, from $5.2 million in the corresponding nine-month period of 2012. Comprising this decrease were planned,
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2013 Third Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Appoints Richard Van Kirk Chief Operating Officer
3. Pro-Dex, Inc. Appoints Harold A. Hurwitz Chief Executive Officer
4. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
5. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
6. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
7. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
8. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
9. Pro-Dex, Inc. Announces Update Conference Call and Webcast
10. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
11. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
(Date:8/31/2015)... ... 2015 , ... India Network Foundation, a non-profit US-based sponsor ... summarizes all available plans, plan maximums, pre-existing condition coverage limits and deductible in ... Network members make an informed decision regarding the care they want for their ...
(Date:8/31/2015)... ... 2015 , ... The Lisle family law firm of Momkus McCluskey, LLC ... his peers to earn a “Leading Lawyers” distinction. , The “Leading ... of Illinois. The nomination process is based on statewide peer survey nominations and the ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... a one-day event geared to patients and family members, medical professionals, and researchers, ... regional mesothelioma experts. The conference is a collaborative effort between the Mesothelioma ...
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, a nonprofit Ohio-based ... In this capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate ... programs that have contributed to the company’s rapid growth. As the CareSource business ...
(Date:8/31/2015)... ... , ... Coast Dental Vista is celebrating its recent grand opening ... p.m. near Albertsons in the Foothill Center, located at 1279 E. Vista Way. There ... Jay Lopp. Call (760) 208-2518 for more details or stop by on September 5. ...
Breaking Medicine News(10 mins):Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3
... Facial expressions convey strong cues for someone,s emotional ... crucial in social interaction. This ability is known to ... as social anxiety or Korsakoff,s syndrome. New research has ... also characterized by changes in the way the brain ...
... 16 (HealthDay News) -- Many women in the United States ... due to dangerous ingredients, a new study indicates. Pai ... which are banned in the United States because they increase ... U.S. Food and Drug Administration announced a recall of Pai ...
... exercise routine means being able to overcome the obstacles ... the confidence that you can do it, researchers report. ... abilities increase this "situation-specific self-confidence," a quality the researchers ... self-efficacy to every single health behavior you can think ...
... You might want to take a pass on that nightcap, ... hinders the restorative functions of sleep. The findings, from ... in the November print issue of the journal Alcoholism: ... sleep appears linked to a disruption in nervous system function. ...
... , MONDAY, Aug. 15 (HealthDay News) -- ,Just 15 minutes ... by 14 percent and increase your life expectancy by three years, ... do at least 150 minutes, or a total of 1.5 hours, ... that doing even half that -- 15 minutes daily is about ...
... public standards incorporating new tests for impurities as well ... of over-the-counter (OTC) ingredients and products will be key ... co-sponsored by the U.S. Food & Drug Administration (FDA) ... addition to providing updates on new standards for acetaminophen ...
Cached Medicine News:Health News:Reduced recognition of fear and sadness in post-traumatic stress disorder 2Health News:U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall 2Health News:Want to keep your exercise resolutions? New research offers pointers 2Health News:Want to keep your exercise resolutions? New research offers pointers 3Health News:More Evidence That Alcohol Hinders Good Sleep 2Health News:A Little Exercise Goes a Long Way to Cut Disease, Death Risk 2Health News:FDA-USP workshop to preview updated OTC standards 2Health News:FDA-USP workshop to preview updated OTC standards 3
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: